We are live on
!
Find out more
SSA
Schonfeld Strategic Advisors Portfolio holdings
AUM
$14.2B
1-Year Est. Return
37.17%
This Fund
S&P 500
This Quarter
Est. Return
+4.29%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.75%
5 Year Est. Return
+136.39%
10 Year Est. Return
+833.52%
AUM
$2.83B
AUM Growth
-$51.8M
(-1.8%)
Cap. Flow
-$96.1M
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
16%
Holding
1,400
New
374
Increased
259
Reduced
316
Closed
442
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NRG Energy
NRG
|
+$61.4M |
| 2 |
Vistra
VST
|
+$60.2M |
| 3 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$44.4M |
| 4 |
ConocoPhillips
COP
|
+$33.8M |
| 5 |
ETFC
E*Trade Financial Corporation
ETFC
|
+$32.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Conagra Brands
CAG
|
+$43.5M |
| 2 |
Target
TGT
|
+$30.5M |
| 3 |
Best Buy
BBY
|
+$28.2M |
| 4 |
Canadian Natural Resources
CNQ
|
+$23.9M |
| 5 |
APU
AmeriGas Partners, L.P.
APU
|
+$20M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.64% |
| 2 | Financials | 15.46% |
| 3 | Consumer Discretionary | 11.37% |
| 4 | Technology | 10.29% |
| 5 | Energy | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Realty Income
O
$60.1B
| $1.9M | 0.07% |
+28,483
| New | +$1.95M |
|
302
Surgery Partners
SGRY
$2.08B
| $1.89M | 0.07% |
+232,000
| New | +$2.31M |
|
|
CARM
303
DELISTED
Carisma Therapeutics
CARM
| $1.88M | 0.07% |
+62,785
| New | +$1.88M |
|
304
Roper Technologies
ROP
$38.5B
| $1.86M | 0.07% |
+5,080
| New | +$1.8M |
|
305
Equitable Holdings
EQH
$13.3B
| $1.86M | 0.07% |
88,900
-409,585
| -82% | -$8.81M |
|
|
RTLR
306
DELISTED
Rattler Midstream LP Common Units
RTLR
| $1.83M | 0.06% |
+94,629
| New | +$1.81M |
|
307
CSX Corp
CSX
$93B
| $1.82M | 0.06% |
70,467
-8,994
| -11% | -$232K |
|
|
WCN
308
Waste Connections
WCN
$41.9B
| $1.8M | 0.06% |
18,800
+264
| +1% | +$24.3K |
|
309
Northern Trust
NTRS
$22.4B
| $1.79M | 0.06% |
19,900
+10,547
| +113% | +$972K |
|
310
Humana
HUM
$44B
| $1.79M | 0.06% |
6,738
+5,396
| +402% | +$1.37M |
|
311
Regions Financial
RF
$26.3B
| $1.78M | 0.06% |
119,200
-60,900
| -34% | -$899K |
|
312
Abeona Therapeutics
ABEO
$369M
| $1.76M | 0.06% |
14,756
+6,000
| +69% | +$1.01M |
|
313
Coherus Oncology
CHRS
$227M
| $1.76M | 0.06% |
79,600
-177,100
| -69% | -$3.08M |
|
314
Trevi Therapeutics
TRVI
$2.61B
| $1.76M | 0.06% |
+234,442
| New | +$2.02M |
|
315
Royal Caribbean
RCL
$86.1B
| $1.76M | 0.06% |
14,500
-90,300
| -86% | -$11M |
|
316
Arvinas
ARVN
$536M
| $1.75M | 0.06% |
+79,700
| New | +$1.67M |
|
|
HZNP
317
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $1.75M | 0.06% |
+72,539
| New | +$1.84M |
|
318
Zymeworks
ZYME
$1.67B
| $1.74M | 0.06% |
+79,200
| New | +$1.45M |
|
|
GRFS
319
Grifois
GRFS
$5.58B
| $1.74M | 0.06% |
82,500
-48,100
| -37% | -$917K |
|
320
Gildan
GIL
$9.72B
| $1.74M | 0.06% |
+44,900
| New | +$1.68M |
|
321
Valmont Industries
VMI
$9.2B
| $1.72M | 0.06% |
13,600
-700
| -5% | -$87.3K |
|
|
LK
322
DELISTED
Luckin Coffee Inc. American Depositary Shares
LK
| $1.72M | 0.06% |
+88,100
| New | +$1.63M |
|
|
ZEN
323
DELISTED
ZENDESK INC
ZEN
| $1.71M | 0.06% |
19,200
-3,800
| -17% | -$327K |
|
324
Keysight
KEYS
$53.4B
| $1.7M | 0.06% |
+18,952
| New | +$1.61M |
|
325
Arch Capital
ACGL
$34.5B
| $1.7M | 0.06% |
+45,900
| New | +$1.57M |
|
Similar funds
FGP
BBVA
IFP
BIP
X
CM
Schonfeld Strategic Advisors's Q2 2019 Portfolio in Review
As of Q2 2019, Schonfeld Strategic Advisors held 1,400 positions worth $2.83B, down 1.8% from $2.88B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Schonfeld Strategic Advisors withdrew a net $96.1M in Q2 2019, closing 442 positions and reducing 316 holdings. Its most notable exit was Conagra Brands, an estimated $43.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Schonfeld Strategic Advisors opened a new position in Equitrans Midstream Corporation Common Stock worth $42.1M.
- Schonfeld Strategic Advisors's largest Q2 2019 buy was Equitrans Midstream Corporation Common Stock: 2,136,064 shares worth $42.1M.
- Schonfeld Strategic Advisors added most to NRG Energy in Q2 2019, an estimated $61.4M increase.
- Schonfeld Strategic Advisors's biggest Q2 2019 reduction was Target, cutting an estimated $30.5M.
- Schonfeld Strategic Advisors fully exited Conagra Brands in Q2 2019, selling an estimated $43.5M.
- Schonfeld Strategic Advisors's ten largest holdings make up 16% of its $2.83B portfolio in Q2 2019.
- Schonfeld Strategic Advisors opened 374 new positions and closed 442 in Q2 2019.
- Schonfeld Strategic Advisors's portfolio value fell 1.8% quarter-over-quarter to $2.83B.
Based on Schonfeld Strategic Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.